Analysis of a two-year independent screening effort for retinopathy of prematurity in rural Egypt

BMC Ophthalmology

Norhan Lotfy Selim¹  Sara Tawfik¹  Mohamed A. Tawfik²  Ahmed M. Habib³  Ahmed Mansour³  Yousef A. Fouad³  Mariam Al-Feky⁴ 

[1] Al Ferdaws Eye Hospital, Sharkia, Egypt;Al Mashreq Eye Center, 102 El-Sayed El-Merghany St., 11774, Cairo, Egypt;Al Ferdaws Eye Hospital, Sharkia, Egypt;Al Mashreq Eye Center, 102 El-Sayed El-Merghany St., 11774, Cairo, Egypt;Memorial Institute for Ophthalmic Research, Giza, Egypt;Al Mashreq Eye Center, 102 El-Sayed El-Merghany St., 11774, Cairo, Egypt;Department of Ophthalmology, Ain Shams University Hospitals, Cairo, Egypt;Al Mashreq Eye Center, 102 El-Sayed El-Merghany St., 11774, Cairo, Egypt;Department of Ophthalmology, Ain Shams University Hospitals, Cairo, Egypt;Watany Eye Hospital, Cairo, Egypt;

关键词: Retinopathy of Prematurity;    ROP;    Screening;    Aggressive Posterior Retinopathy of Prematurity;    Ranibizumab;   

DOI  :  10.1186/s12886-021-02193-x

来源: Springer

【 摘 要 】

BackgroundThe third epidemic of retinopathy of prematurity (ROP) has majorly involved middle income countries in which tailored screening and local guidelines require development. The data regarding ROP prevalence and cutoff numbers for screening in Egypt are lacking.MethodsRetrospective analysis of an independent screening effort spanning 2 years (February 2019 to February 2021) and involving 32 neonatal care units within Sharkia governorate, Egypt. Infants of gestational age (GA) ≤ 34 weeks and/or birth weight (BW) ≤ 2000 g were included, as well as those with unstable clinical course. Two eyecare centers located in Sharkia and Cairo governorates served as referral centers for any required interventions.ResultsOf the 276 screened infants, 133 (48.2%) had some form of ROP that was bilateral in 127 (95.5%) of them. Aggressive posterior ROP (AP-ROP) was detected in both eyes of 24 infants (8.7%). The median (IQR) GA of infants with ROP was 32 (30–34) weeks, and the median (IQR) BW was 1600 (1350–2000) g. Sixty-three infants (47.4%) required treatment. Of the total 84 eyes that primarily were treated, 73 (86.9%) received intravitreal ranibizumab, 8 (9.5%) underwent laser ablation therapy, and 3 eyes (3.6%) underwent surgery. Recurrence rate was 16.7% (14 eyes). Final outcome was favorable in 83 eyes (98.8%). Applying the American Academy criteria would have led to the missing of 36.8% of infants with ROP and 28.6% of those requiring treatment in our sample.ConclusionThe incidence of both ROP and AP-ROP in the Egyptian rural setting appears to be in the high end of global reported rates. Prevention measures should urgently be planned and implemented.

【 授权许可】

CC BY